Literature DB >> 23772851

Decreased plasma adiponectin is associated with impaired left ventricular longitudinal systolic function in hypertensive patients: a two-dimensional speckle tracking study.

Birol Özkan1, Göksel Açar, Gökhan Alıcı, Elnur Alizade, Mehmet Mustafa Tabakcı, Müslüm Sahin, Mehmet Vefik Yazıcıoğlu, Abdullah Ozkok, Ibrahim Halil Tanboğa, Cihan Coşkun, Ali Metin Esen.   

Abstract

The influence of plasma adiponectin levels on myocardial contractile function has not been fully examined. We aimed to investigate the relationship between three-directional systolic function and plasma adiponectin levels in asymptomatic hypertensive patients using two- dimensional speckle-tracking echocardiography. The study population consisted of 78 patients with hypertension and 40 healthy controls. Longitudinal strain was significantly reduced in all patients, including those without LV hypertrophy (p=0.009). In multiple-regression analysis, plasma adiponectin levels (β=-0.273, p=0.008) and LV mass index (β=0.458, p<0.001) independently correlated with LV longitudinal strain. Decreased plasma adiponectin concentrations were associated with the progression of LV hypertrophy with impaired LV longitudinal systolic function.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23772851     DOI: 10.3109/10641963.2013.783053

Source DB:  PubMed          Journal:  Clin Exp Hypertens        ISSN: 1064-1963            Impact factor:   1.749


  2 in total

1.  Left Ventricular Diastolic and Systolic Functions in Patients with Hypothyroidism.

Authors:  Rina Tafarshiku; Michael Y Henein; Venera Berisha-Muharremi; Ibadete Bytyçi; Pranvera Ibrahimi; Afrim Poniku; Shpend Elezi; Gani Bajraktari
Journal:  Medicina (Kaunas)       Date:  2020-10-07       Impact factor: 2.430

2.  Long-term Effects of high-doSe pitavaStatin on Diabetogenicity in comparison with atorvastatin in patients with Metabolic syndrome (LESS-DM): study protocol for a randomized controlled trial.

Authors:  Jun-Bean Park; Ji-Hyun Jung; Yeonyee E Yoon; Hack-Lyong Kim; Seung-Pyo Lee; Hyung-Kwan Kim; Yong-Jin Kim; Goo-Yeong Cho; Dae-Won Sohn
Journal:  Trials       Date:  2017-10-27       Impact factor: 2.279

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.